A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know
West executed a sale under a pre-established Rule 10b5-1 trading plan, reducing her direct stake by 8% while retaining 34,981 shares worth roughly $1.8 million.
Overview
Nadja West, a director at Tempus AI, Inc. (NASDAQ:TEM), sold 3,000 shares of Class A Common Stock on August 14 at $53.90 per share, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($53.90); post-transaction value based on the August 14 market close ($52.10).
Details
Tempus AI is a healthcare technology company headquartered in Chicago, with a market capitalization of $9.0 billion and approximately 3,800 employees. The company has achieved TTM revenue of $1.4 billion while investing heavily in platform development and market expansion, as evidenced by its current net loss position. Tempus AI's competitive differentiation stems from its integrated platform architecture that combines clinical workflow optimization with advanced diagnostic analytics, positioning it as a comprehensive solution provider in the precision medicine and genomic testing landscape.
Source
Originally published at www.fool.com.